SRPT — Sarepta Therapeutics Share News
0.000.00%
Last trade - 00:00- $1.88bn
- $1.94bn
- $2.20bn
U.S. STOCKS ON THE MOVE-Lemonade, New York Times, Johnson Controls
Sarepta rises after Mizuho upgrades rating, lifts PT on Elevidys adoption
U.S. STOCKS ON THE MOVE-Marriott, Leidos, McDonald's
U.S. STOCKS ON THE MOVE-Hims & Hers Health, Hertz Global, Metsera
U.S. STOCKS ON THE MOVE-Yum Brands, Waters, Harley-Davidson
Sarepta slumps after approved muscle disorder drugs fail confirmatory trial
Sarepta slumps as trial failure deepens woes for drugmaker (updated)
Sarepta slumps as gene therapy setback adds to drug pipeline woes
Sarepta shares dive as gene therapy misses late-stage main goal
Sarepta Therapeutics Q3 revenue beats estimates on strong show from gene therapy ELEVIDYS
Sarepta's Duchenne gene therapy misses main goal in late-stage study; shares fall (updated)
Sarepta's Duchenne gene therapy misses main goal in study
Brief: Sarepta Therapeutics To Announce Third Quarter 2025 Financial Results
U.S. RESEARCH ROUNDUP- AGCO, Caterpillar, United Rentals
U.S. RESEARCH ROUNDUP- IQVIA Holdings, Reliance, United Therapeutics
U.S. STOCKS ON THE MOVE- Shoe Carnival, Leidos Holdings, copper miners
U.S. STOCKS ON THE MOVE- Gap, Aquestive Therapeutics, Lumentum
U.S. STOCKS ON THE MOVE-Bruker Corp, Centuri Holdings, Shoe Carnival
US FDA program favorable for rare disease drug developers, says Jefferies